These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9587045)

  • 1. Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital.
    Harder S; Thürmann P; Thierolf C; Klepzig H
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):195-201. PubMed ID: 9587045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differences in pharmacologic treatment after acute myocardial infarction. The role of treatment effectiveness].
    Bobbio M; Imazio M; Tidu M; Presbitero P; Trinchero R; Brusca A
    G Ital Cardiol; 1997 Jun; 27(6):549-56. PubMed ID: 9280724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
    Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
    Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E; Pettersen KI; Landmark K; Reikvam A;
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective review of the medical records of cardiology hospital outpatient clinics with the aim of determining the therapeutic approach to patients suffering from high blood pressure and/or dyslipidemia.
    Rato Q; Cardoso AA
    Rev Port Cardiol; 2006 Oct; 25(10):889-905. PubMed ID: 17190239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the management of patients after myocardial infarction, from admission to discharge.
    Amin A
    Clin Ther; 2006 Oct; 28(10):1509-39. PubMed ID: 17157110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
    Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
    Winkelmayer WC; Charytan DM; Levin R; Avorn J
    Am J Kidney Dis; 2006 Feb; 47(2):301-8. PubMed ID: 16431259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of an anesthesia information system to identify and trend gender disparities in outpatient medical management of patients with coronary artery disease.
    Vigoda MM; Rodríguez LI; Wu E; Perry K; Duncan R; Birnbach DJ; Lubarsky DA
    Anesth Analg; 2008 Jul; 107(1):185-92. PubMed ID: 18635487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive adrenergic blockade post myocardial infarction left ventricular dysfunction.
    Fonarow GC
    Cardiol Clin; 2008 Feb; 26(1):79-89, vii. PubMed ID: 18312908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006.
    Sepehri G; Talebizadeh N; Mirzazadeh A; Mohsenbeigi M
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):180-5. PubMed ID: 18001003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
    Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimamoto K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimada K; Tanaka H; Yoshiike N;
    Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.